Cargando…

Development and external validation of the Psychosis Metabolic Risk Calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosis

BACKGROUND: Young people with psychosis are at high risk of developing cardiometabolic disorders; however, there is no suitable cardiometabolic risk prediction algorithm for this group. We aimed to develop and externally validate a cardiometabolic risk prediction algorithm for young people with psyc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perry, Benjamin I, Osimo, Emanuele F, Upthegrove, Rachel, Mallikarjun, Pavan K, Yorke, Jessica, Stochl, Jan, Perez, Jesus, Zammit, Stan, Howes, Oliver, Jones, Peter B, Khandaker, Golam M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211566/ https://www.ncbi.nlm.nih.gov/pubmed/34087113 http://dx.doi.org/10.1016/S2215-0366(21)00114-0

Ejemplares similares

An International External Validation and Revision of the PsyMetRiC Cardiometabolic Risk Prediction Algorithm for Young People with Psychosis
por: Perry, B., et al.
Publicado: (2022)

The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples
por: Perry, Benjamin I., et al.
Publicado: (2022)

Longitudinal Trends in Childhood Insulin Levels and Body Mass Index and Associations With Risks of Psychosis and Depression in Young Adults
por: Perry, Benjamin I., et al.
Publicado: (2021)

Predicting treatment resistance in people with a first-episode of psychosis using commonly recorded clinical information
por: Osimo, E.F., et al.
Publicado: (2022)

Predicting treatment resistance from first-episode psychosis using routinely collected clinical information
por: Osimo, Emanuele F., et al.
Publicado: (2023)

Longitudinal population subgroups of CRP and risk of depression in the ALSPAC birth cohort
por: Osimo, Emanuele F., et al.
Publicado: (2020)

Dysglycaemia, Inflammation and Psychosis: Findings From the UK ALSPAC Birth Cohort
por: Perry, Benjamin Ian, et al.
Publicado: (2019)

Persistent Childhood and Adolescent Anxiety and Risk for Psychosis: A Longitudinal Birth Cohort Study
por: Morales-Muñoz, Isabel, et al.
Publicado: (2022)

Longitudinal association between CRP levels and risk of psychosis: a meta-analysis of population-based cohort studies
por: Osimo, Emanuele F., et al.
Publicado: (2021)

30.3 ASSOCIATION BETWEEN SERUM C-REACTIVE PROTEIN, POSITIVE AND NEGATIVE SYMPTOMS OF PSYCHOSIS IN A GENERAL POPULATION-BASED BIRTH COHORT
por: Khandaker, Golam, et al.
Publicado: (2018)

Association between circulating levels of C-reactive protein and positive and negative symptoms of psychosis in adolescents in a general population birth cohort
por: Khandaker, Golam M., et al.
Publicado: (2021)

Cardiometabolic Risk in First Episode Psychosis Patients
por: Smith, Jo, et al.
Publicado: (2020)

Inflammatory and cardiometabolic markers at presentation with first episode psychosis and long-term clinical outcomes: A longitudinal study using electronic health records
por: Osimo, Emanuele F., et al.
Publicado: (2021)

Childhood inflammatory markers and risks for psychosis and depression at age 24: Examination of temporality and specificity of association in a population-based prospective birth cohort
por: Perry, Benjamin I., et al.
Publicado: (2021)

Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort
por: Khandaker, Golam M., et al.
Publicado: (2018)

Substance use in people at clinical high-risk for psychosis
por: Russo, Debra A, et al.
Publicado: (2014)

Common mechanisms for type 2 diabetes and psychosis: Findings from a prospective birth cohort
por: Perry, Benjamin I., et al.
Publicado: (2020)

T80. CARDIOMETABOLIC RISK PREDICTION ALGORITHMS AND THEIR APPLICABILITY FOR YOUNG PEOPLE WITH PSYCHOSIS: A SYSTEMATIC REVIEW AND ILLUSTRATIVE EXAMPLE USING ORIGINAL DATA FROM A POPULATION-BASED BIRTH COHORT
por: Jang, Soomin, et al.
Publicado: (2020)

A review of economic evaluations of health care for people at risk of psychosis and for first-episode psychosis
por: Shields, Gemma E., et al.
Publicado: (2022)

Psychosis risk syndrome is not prodromal psychosis
por: XU, Lihua, et al.
Publicado: (2015)

S13. DO PATIENTS WITH RECENT-ONSET DEPRESSION DIFFER CLINICALLY AND NEUROBIOLOGICALLY FROM DEPRESSED PATIENTS WITH A CLINICAL HIGH-RISK STATE FOR PSYCHOSIS?
por: Upthegrove, Rachel, et al.
Publicado: (2018)

Inflammation subtypes in psychosis and their relationships with genetic risk for psychiatric and cardiometabolic disorders
por: Zhang, Lusi, et al.
Publicado: (2022)

Association of Childhood Infection With IQ and Adult Nonaffective Psychosis in Swedish Men: A Population-Based Longitudinal Cohort and Co-relative Study
por: Khandaker, Golam M., et al.
Publicado: (2018)

Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk
por: Barron, Henry, et al.
Publicado: (2017)

Pattern of predictive features of continued cannabis use in patients with recent-onset psychosis and clinical high-risk for psychosis
por: Penzel, Nora, et al.
Publicado: (2022)

Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
por: Pillinger, Toby, et al.
Publicado: (2018)

The impact of visual dysfunctions in recent-onset psychosis and clinical high-risk state for psychosis
por: Schwarzer, Johanna M., et al.
Publicado: (2022)

Recognition and management of depression in early psychosis
por: Bashir, Zainab, et al.
Publicado: (2022)

Correction to: Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
por: Pillinger, Toby, et al.
Publicado: (2018)

Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis
por: Foley, Éimear M, et al.
Publicado: (2023)

Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study
por: Gaughran, Fiona, et al.
Publicado: (2019)

Aberrant salience network functional connectivity in auditory verbal hallucinations: a first episode psychosis sample
por: Mallikarjun, Pavan Kumar, et al.
Publicado: (2018)

F154. ABERRANT SALIENCE NETWORK FUNCTIONAL CONNECTIVITY IN AUDITORY VERBAL HALLUCINATIONS: A FIRST EPISODE PSYCHOSIS SAMPLE
por: Lalousis, Paris Alexandros, et al.
Publicado: (2018)

Trauma history characteristics associated with mental states at clinical high risk for psychosis
por: Russo, Debra A., et al.
Publicado: (2014)

Improving Pathways to Care for Patients at High Psychosis Risk in Switzerland: PsyYoung Study Protocol
por: Conchon, Caroline, et al.
Publicado: (2023)

Clozapine treatment and risk of COVID-19
por: Osimo, Emanuele F., et al.
Publicado: (2022)

Longitudinal association between inflammatory markers and specific symptoms of depression in a prospective birth cohort
por: Chu, Alexander L., et al.
Publicado: (2019)

A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis
por: Pillinger, Toby, et al.
Publicado: (2019)

Cardiometabolic Risk Indicators That Distinguish Adults with Psychosis from the General Population, by Age and Gender
por: Foley, Debra L., et al.
Publicado: (2013)

Neural and Behavioral Correlates of Aberrant Salience in Individuals at Risk for Psychosis
por: Roiser, Jonathan P., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_31v5m0fpf5mpaefbhil5mui30k